Oncology

                   

ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide

finanznachrichten.de
yesterday 4 related
        

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society...

add comment
                   

Cancer Patients in Southern Florida Now Benefiting from RapidArc(TM) Radiotherapy Technology at...

finanznachrichten.de
yesterday 3 related
        

PALO ALTO, Calif., Nov. 17 /PRNewswire-FirstCall/ -- Vogel found his way to the Innovative Cancer Institute in South Florida where Dr. Beatriz Amendola, a radiation oncologist, had just begun using RapidArc(TM) radiotherapy...

add comment
                   

BIO-Europe 2008 meldt hoogtepunten van nieuw programma

nieuwsbank.nl
yesterday 4 related
        

Maandag 17 november 2008 | Business Wire ] CARLSBAD, Californië & WASHINGTON--(BUSINESS WIRE)--14 okt, 2008-- Nog een maand en dan vindt op 17 tot en met 19 november het BIO-Europe 2008, 's werelds grootste 'stand-alone'...

add comment
                   

Napier online health project praised at awards ceremony

scotsman.com
yesterday
        

Published Date: 17 November 2008 A CITY university project has been praised by industry professionals in a national awards scheme. Napier University's health online project was highly commended at The Excellence in Oncology...

add comment
                   

Japan M&A: Prescription for growth

financeasia.com
yesterday 2 related
        

By Sameera Anand | 17 November 2008 The cross-border acquisitions that Japan’s pharmaceutical companies are announcing could be just what the doctor ordered, even though they come with hefty price tags. Japanese pharmaceutical...

add comment
                   

Cancer Treatment May Result In Bone Loss

medicalnewstoday.com
yesterday
        

New cross-Canada study in Journal of Clinical Oncology outlines risks A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology,...

add comment
                   

Cleveland Clinic Recognizes Circulating Tumor Cell Technology As Top Medical Innovation For 2009

medicalnewstoday.com
16-Nov-2008
        

Veridex, LLC announced today that the technology used in the CellSearch® System to measure circulating tumor cells (CTCs) was ranked as the top medical innovation for 2009 by the Cleveland Clinic, a leading multispecialty...

add comment

New Venture to Support Cancer Practices in Tough Times

prweb.com
15-Nov-2008 1 related
        

Three prominent community cancer experts form new venture to help community cancer providers. The company, based in Hudson, Ohio, will focus on the enhancement of practice efficiency, provider/patient financial tools, and data...

add comment
                   

Study First To Combine 2 Chemotherapies And 2 Targeted Therapies

medicalnewstoday.com
14-Nov-2008 44 related
        

The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a...

add comment
                   

Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent...

medicalnewstoday.com
14-Nov-2008 8 related
        

Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of...

add comment